Absci (ABSI)
Designs antibody drug candidates with generative AI and validates them in its own wet lab.
$10.80
After-hours close+0.12 (+1.09%)
At close$10.69(+8.81%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | ≈ 88.07% | 151.13M shares | |
|---|---|---|---|
| 208 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 7.63% | 13.09M shares | |
| 11 holders · as of Sep 1, 2026 | |||
| Other | ≈ 4.30% | 7.39M shares | |
| remainder | |||
171.61M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
13F, as of Jun 30, 2026
208 holders · 151.13M shares · 54 new positions · 129 increased · 49 reduced · 16 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| FMR LLC | 25.41M | 14.81% | +2.86M | Aug 13, 2026 |
| Ark Investment Management LLC | 12.93M | 7.53% | −800.9K | Aug 14, 2026 |
| BlackRock, Inc. | 12.18M | 7.09% | +920.1K | Aug 7, 2026 |
| State Street Corp | 8.10M | 4.72% | +772.5K | Aug 7, 2026 |
| Ameriprise Financial Inc | 6.99M | 4.07% | +3.81M | Aug 14, 2026 |
| Redmile Group, LLC | 6.74M | 3.93% | −1.51M | Aug 14, 2026 |
| Vanguard Capital Management LLC | 6.12M | 3.57% | +236.0K | Aug 13, 2026 |
| Advanced Micro Devices Inc | 5.71M | 3.33% | 0 | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| FMR LLC | 14.40% | 18.39M | 13G | May 12, 2025 |
| ARK Investment Management LLC | 8.60% | 10.96M | 13G | May 14, 2025 |
| Sean McClain | 7.20% | 11.00M | 13G | Nov 13, 2025 |
| BlackRock, Inc. | 6.50% | 8.32M | 13G | Jul 16, 2025 |
| Redmile Group, LLCincl. Jeremy C. Green | 5.40% | 8.25M | 13D | Mar 26, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jun 30, 2026 | Mary T. Szeladirector | Purchase | 12,900 | $11.54 | 21,300 |
| May 13, 2026 | Menelas N. Pangalosdirector | Purchase | 37,453 | $5.36 | 232,308 |
| Mar 12, 2026 | Andreas Buschofficer: Chief Innovation Officer | Purchase | 100,000 | $2.29 | 421,446 |
| Feb 27, 2026 | Menelas N. Pangalosdirector | Purchase | 75,095 | $2.74 | 189,055 |
| Feb 2, 2026 | Zachariah Jonassonofficer: CFO / CBO | Sale | 17,496 | $2.99 | 383,538 |
| Feb 2, 2026 | Sean McClaindirector, officer: Chief Executive Officer | Sale | 26,761 | $2.99 | 8,334,567 |
| Dec 5, 2025 | Frans van Houtendirector | Purchase | 40,000 | $3.72 | 63,320 |
| Sep 22, 2025 | Todd Bedrickofficer: SVP, CAO | Purchase | 10,000 | $2.70 | 180,428 |
| Sep 22, 2025 | Menelas N. Pangalosdirector | Purchase | 95,785 | $2.66 | 113,960 |
House and Senate disclosures
Not reported.